http://orcid.org/0000-0001-6035-6381
References
- Vos N, Oyen R. Renal angiomyolipoma: the good, the bad, and the ugly. J Belg Soc Radiol. 2018;102:41.
- Brandt MP, Tsaur I, Vallo S, et al. Ruptured angiomyolipoma of the kidney: a rare differential diagnosis of flank pain. Scand J Urol. 2017;51:342–344.
- Wang C, Li X, Peng L, et al. An update on recent developments in rupture of renal angiomyolipoma. Medicine (Baltimore). 2018;97:e0497.
- Buj Pradilla MJ, Balleste TM, Torra R, et al. Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex. Clin Kidney J. 2017;10:728–737.
- Bernstein J, Robbins TO, Kissane JM. The renal lesions of tuberous sclerosis. Semin Diagn Pathol. 1986;3:97–105.
- Fernandez-Pello S, Gonzalez Rodriguez I, Villamil LR, et al. Laparoscopic management of right renal angiomyolipoma with involvement of the inferior vena cava: case report and review of the literature. Scand J Urol. 2013;47:340–344.
- Oesterling JE, Fishman EK, Goldman SM, et al. The management of renal angiomyolipoma. J Urol. 1986;135:1121–1124.
- Murray TE, Doyle F, Lee M. Transarterial embolization of angiomyolipoma: a systematic review. J Urol. 2015;194:635–639.
- Wang C, Yang M, Tong X, et al. Transarterial embolization for renal angiomyolipomas: a single centre experience in 79 patients. J Int Med Res. 2017;45:706–713.
- Volpe A, Panzarella T, Rendon RA, et al. The natural history of incidentally detected small renal masses. Cancer. 2004;100:738–745.
- Bhatt JR, Richard PO, Kim NS, et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy. Eur Urol. 2016;70:85–90.
- Seyam RM, Bissada NK, Kattan SA, et al. Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology. 2008;72:1077–1082.
- Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372:657–668.
- Franz DN. Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis. Expert Rev Anticancer Ther. 2011;11:1181–1192.
- Sooriakumaran P, Gibbs P, Coughlin G, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int. 2010;105:101–106.
- Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168:1315–1325.
- Mues AC, Palacios JM, Haramis G, et al. Contemporary experience in the management of angiomyolipoma. J Endourol. 2010;24:1883–1886.
- Northrup H, Krueger DA, Northrup H, et al. Tuberous Sclerosis Complex Consensus, Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:243–254.
- Soulen MC, Faykus MH, Jr., Shlansky-Goldberg RD, et al. Elective embolization for prevention of hemorrhage from renal angiomyolipomas. J Vasc Interv Radiol. 1994;5:587–591.
- Ouzaid I, Autorino R, Fatica R, et al. Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int. 2014;114:412–417.
- Danforth TL, Lane BR, Novick AC. Conservative management of giant symptomatic angiomyolipomas in patients with the tuberous sclerosis complex. BJU Int. 2007;100:794–797.
- De Luca S, Terrone C, Rossetti SR. Management of renal angiomyolipoma: a report of 53 cases. BJU Int. 1999;83:215–218.
- Hadley DA, Bryant LJ, Ruckle HC. Conservative treatment of renal angiomyolipomas in patients with tuberous sclerosis. Clin Nephrol. 2006;65:22–27.